See also this year's filing and all EDGAR filings for this company.
PDF Report 0001610820_2024_Briacell_Therapeutics_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001610820', 'EntityCommonStockSharesOutstanding': 15981726, 'Assets': 27163577, 'AssetsCurrent': 26948507, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 215068, 'Liabilities': 30940758, 'LiabilitiesAndStockholdersEquity': 27163577, 'LiabilitiesCurrent': 1801457, 'LiabilitiesNoncurrent': 29139301, 'NetIncome': -20302394, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 2, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': -3777181, 'remainder_NetIncome': -20302394, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |